52-Week Highs and Lows, May 8, 2026

15 highs, 7 lows.

Highs

LNTH .. $94.86 .. Lantheus Holdings. Q1 beat on Thursday with revenue of $377M and adjusted EPS of $1.46 versus $1.24 estimate. PYLARIFY TruVu got FDA approval with a phased Q4 launch and PNT2003 received tentative approval for GEP-NETs. Radiopharm leadership keeps the bid.

CVS .. $90.89 .. CVS Health. Q1 revenue of $100.4B with adjusted EPS of $2.57 versus $2.21 estimate. Management raised full year guidance to $7.30 to $7.50 from $7.00 to $7.20 on Aetna margin recovery. The turnaround is working.

ASTH .. $39.90 .. Astrana Health. Q1 revenue of $965M, up 56% year over year, adjusted EPS of $0.74 versus $0.29 estimate. Needham raised its target to $41 and BTIG raised to $50. AI-enabled full risk platform delivering operating leverage at scale.

TGTX .. $44.00 .. TG Therapeutics. Briovi commercial momentum keeps multiple sclerosis franchise expanding. The stock failed at the high and closed near $42.86, watch the follow through.

ACRS .. $4.94 .. Aclaris Therapeutics. Continued strength after the Q1 print on May 7 with the JAK3 program advancing.

PHVS .. $31.47 .. Pharvaris. Hereditary angioedema oral pipeline continues to attract capital ahead of late stage data.

CADL .. $8.36 .. Candel Therapeutics. Viral immunotherapy story holding bid as oncology specialty names get rotated into.

LXRX .. $2.00 .. Lexicon Pharmaceuticals. Post print bid after the May 8 update on Inpefa cardiovascular positioning and Sotagliflozin pipeline.

OCS .. $32.76 .. Oculis Holding. Ophthalmic specialty platform with continued momentum into mid year readouts. Miami Tier 3 carryover.

PTNT .. $25.75 .. Corgi IP Licensing. IP licensing platform continues to bid on the income theme.

CASY .. $868.08 .. Casey's General Stores. Convenience retail compounder keeps printing new highs as fuel margins stabilize.

QQQM .. $292.82 .. Invesco Nasdaq 100 ETF. Mega cap tech bid continues to lift the broad index complex.

VTI .. $362.72 .. Vanguard Total Stock Market ETF. Broad US market new high.

VXUS .. $85.78 .. Vanguard Total International Stock ETF. International continues to participate, dollar weakness helping.

Lows

ABT .. $84.08 .. Abbott Laboratories. Diversified diagnostics and medical device large cap continues to slide on broader healthcare megacap rotation.

KBR .. $31.56 .. KBR Inc. Government services name under pressure on budget concerns and contract delays.

QGEN .. $32.92 .. Qiagen. Molecular diagnostics name making a new low after a soft start to the year.

ORGO .. $2.04 .. Organogenesis. Post Q1 disaster continues to grind lower on advanced wound care reimbursement pressure.

ARTL .. $2.51 .. Artelo Biosciences. Micro cap biotech meltdown continues, no clear catalyst path.

CAI .. $15.71 .. Caris Life Sciences. New 52 week low despite strong Q1 print, three brokers cut price targets the same day. Story is worth a deeper look this week.

AKBA .. $1.12 .. Akebia Therapeutics. Vafseo continues to disappoint on commercial uptake, dollar one handle is now in play.

Summary

Healthcare large cap split sharply on Friday. CVS, LNTH, and ASTH all printed Q1 beats and ripped to new highs, while ABT continued its slide. Biotech kept a clear bid with ACRS, LXRX, CADL, PHVS, TGTX, and OCS all marking highs, mostly small and mid cap pipeline names. The broad ETF complex (QQQM, VTI, VXUS) hit new highs together, signaling participation across US large cap, total market, and international. The standout story on the lows is CAI, where a strong fundamental print got outweighed by simultaneous price target cuts from three brokers, creating a setup worth watching on Sunday. Casey's keeps compounding to fresh highs in retail.